Defining the risks of mesenchymal stromal cell therapy

  • Prockop D
  • Brenner M
  • Fibbe W
 et al. 
  • 101


    Mendeley users who have this article in their library.
  • 173


    Citations of this article.


Abstract We address the issue of the potential for malignant transformation of cultured mesenchymal stromal cells (MSC) commonly used in clinical cell-therapy protocols and describe the culture conditions under which tumorigenesis is likely to be an extremely uncommon event.

Author-supplied keywords

  • Cell contamination
  • MSCs
  • Mesenchymal stem cells

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Darwin J. Prockop

  • Malcolm Brenner

  • Willem E. Fibbe

  • Edwin Horwitz

  • Katarina Le Blanc

  • Donald G. Phinney

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free